[Ofloxacin in mycobacteriosis therapy].
Padełskaya
E N
EN
D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D015441:Leprosy, Tuberculoid / Q000188:drug therapy; D051379:Mice; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects / Q000201:enzymology; D009164:Mycobacterium Infections / Q000188:drug therapy*; D015242:Ofloxacin / Q000627:therapeutic use*; D059005:Topoisomerase II Inhibitors; D014376:Tuberculosis / Q000188:drug therapy
D000890:Anti-Infective Agents; D059005:Topoisomerase II Inhibitors; D015242:Ofloxacin
Ofloksatsin v terapii mikobakteriozov